Human chorionic gonadotropin as a biological marker in breast carcinoma

Rasim A. Gucalp, D. Firat

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Serum HCG levels were determined in benign and malignant breast tumor patients. Serum HCG levels were elevated in 1/18 (5.6%) benign, 8/27 (29.6%) localised and 15/41 (36.6%) metastatic breast carcinoma cases. The incidence of HCG elevation increased with multiple sites of involvement. The incidence of HCG elevation was similar for different organ sites of involvement. In view of these observations, the serum HCG levels may be of value in the differentiation of benign and malignant breast tumors, but have no value in the staging of breast carcinomas.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalKanser
Volume10
Issue number1
StatePublished - 1980
Externally publishedYes

Fingerprint

Chorionic Gonadotropin
Biomarkers
Breast Neoplasms
Serum
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Human chorionic gonadotropin as a biological marker in breast carcinoma. / Gucalp, Rasim A.; Firat, D.

In: Kanser, Vol. 10, No. 1, 1980, p. 23-30.

Research output: Contribution to journalArticle

@article{905167830dcc465e9f72bae2b8aceb7e,
title = "Human chorionic gonadotropin as a biological marker in breast carcinoma",
abstract = "Serum HCG levels were determined in benign and malignant breast tumor patients. Serum HCG levels were elevated in 1/18 (5.6{\%}) benign, 8/27 (29.6{\%}) localised and 15/41 (36.6{\%}) metastatic breast carcinoma cases. The incidence of HCG elevation increased with multiple sites of involvement. The incidence of HCG elevation was similar for different organ sites of involvement. In view of these observations, the serum HCG levels may be of value in the differentiation of benign and malignant breast tumors, but have no value in the staging of breast carcinomas.",
author = "Gucalp, {Rasim A.} and D. Firat",
year = "1980",
language = "English (US)",
volume = "10",
pages = "23--30",
journal = "Kanser",
issn = "0377-9750",
publisher = "Turkish Association for Cancer Research and Control",
number = "1",

}

TY - JOUR

T1 - Human chorionic gonadotropin as a biological marker in breast carcinoma

AU - Gucalp, Rasim A.

AU - Firat, D.

PY - 1980

Y1 - 1980

N2 - Serum HCG levels were determined in benign and malignant breast tumor patients. Serum HCG levels were elevated in 1/18 (5.6%) benign, 8/27 (29.6%) localised and 15/41 (36.6%) metastatic breast carcinoma cases. The incidence of HCG elevation increased with multiple sites of involvement. The incidence of HCG elevation was similar for different organ sites of involvement. In view of these observations, the serum HCG levels may be of value in the differentiation of benign and malignant breast tumors, but have no value in the staging of breast carcinomas.

AB - Serum HCG levels were determined in benign and malignant breast tumor patients. Serum HCG levels were elevated in 1/18 (5.6%) benign, 8/27 (29.6%) localised and 15/41 (36.6%) metastatic breast carcinoma cases. The incidence of HCG elevation increased with multiple sites of involvement. The incidence of HCG elevation was similar for different organ sites of involvement. In view of these observations, the serum HCG levels may be of value in the differentiation of benign and malignant breast tumors, but have no value in the staging of breast carcinomas.

UR - http://www.scopus.com/inward/record.url?scp=0019159709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019159709&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 23

EP - 30

JO - Kanser

JF - Kanser

SN - 0377-9750

IS - 1

ER -